Skip to main content
Log in

Rationale for active vitamin D analog therapy in senile osteoporosis

  • Satellite Symposium on New Aspects in Therapy With Active Vitamin D Derivatives May 19, 1996 Amsterdam, The Netherlands
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Conclusion

PTH is a potent endogenous stimulator of bone resorption, and PTH secretion increases with age (i.e., secondary hyperparathyroidism). Accordingly, secondary hyperparathyroidism may contribute to the pathogenesis of senile osteoporosis. We postulate that there is a subgroup of elderly subjects who have elevated serum PTH because of 1,25(OH)2D3 deficiency/resistance or both. We believe that with appropriate vitamin D therapy (vitamin D, 1,25(OH)2D3 or 1α(OH)D3) and adequate calcium, much of the problem associated with secondary hyperparathyroidism seen in the senile osteoporotic patient can be effectively treated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Makin G, Lohnes D, Byford V, Ray R, Jones G (1989) Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262:173–80

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Minghetti PP, Norman AW (1988) l,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J 2:3043–3053

    CAS  PubMed  Google Scholar 

  3. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF (1979) Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206: 1188–1190

    Article  CAS  PubMed  Google Scholar 

  4. Nemere I, Zhou LX, Norman AW (1993) Nontranscriptional effects of steroid hormones. Receptor 3:277–291

    CAS  PubMed  Google Scholar 

  5. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889–895

    Article  CAS  PubMed  Google Scholar 

  6. Umesono K, Murakami KK, Thompson CC, Evans RM (1991) Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255–1266

    Article  CAS  PubMed  Google Scholar 

  7. Pols HA, van Leeuwen JP, Schilte JP, Visser TJ, Birkenhager JC (1988) Heterologous up-regulation of the 1,25-dihydroxy-vitamin D3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells. Biochem Biophys Res Comm 156:588–594

    Article  CAS  PubMed  Google Scholar 

  8. Reinhardt TA, Horst RL (1990) Parathyroid hormone downregulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Endocrinology 127:942–948

    Article  CAS  PubMed  Google Scholar 

  9. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367:284–287

    Article  CAS  PubMed  Google Scholar 

  10. Looney JE, Yoon HK, Fischer M, Farley SM, Farley JR, Wergedal JE, Baylink DJ (1995) Lack of high prevalence of the BB vitamin D receptor genotype in severely osteoporotic women. J Clin Endocrinol Metab 80:2158–2162

    CAS  PubMed  Google Scholar 

  11. Peacock M (1995) Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J Bone Miner Res 10:1294–1297

    Article  CAS  PubMed  Google Scholar 

  12. Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K (1992) 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the posttranscriptional level. Cytokine 4:506–512

    Article  CAS  PubMed  Google Scholar 

  13. Finkelman RD, Linkhart TA, Mohan S, Lau KHW, Baylink DJ, Bell NH (1991) Vitamin D deficiency causes a selective reduction in the deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. Proc Natl Acad Sci 88:3657–3660

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Chertow BS, Baylink DJ, Wergedal JE, Su MH, Norman AW (1975) Decrease in serum immunoreactive parathyroid hormone in rats and in PTH secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest 56:668–678

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Toss G, Almqvist S, Larsson L, Zetterqvist H (1980) Vitamin D deficiency in welfare institutions for the aged. Acta Med Scand 208:87–89

    Article  CAS  PubMed  Google Scholar 

  16. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM (1995) Vitamin D status and sex hormone-binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10:1177–1184

    Article  CAS  PubMed  Google Scholar 

  17. Francis RM, Peacock M (1987) Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis. Am J Clin Nutr 46:315–318

    CAS  PubMed  Google Scholar 

  18. Brazier M, Kamel S, Maamer M, Agbomson F, Elesper I, Garabedian M, Desmet G, Sebert JL (1995) Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction. J Bone Miner Res 10:1753–1761

    Article  CAS  PubMed  Google Scholar 

  19. Lips P, Netelenbos JC, Jongen MJM, van Ginkel FC, Althuis AL, van Schaik CL, van der Vijgh WJ, Vermeiden JP, van der Meer C (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Rel Res 4:85–93

    Article  CAS  Google Scholar 

  20. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier JP (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637–1642

    Article  CAS  PubMed  Google Scholar 

  21. Epstein S, Bryce G, Hinman JW, Miller ON, Riggs BL, Hui SL, Johnston CC Jr (1986) The influence of age on bone mineral regulating hormones. Bone 7:421–425

    Article  CAS  PubMed  Google Scholar 

  22. Slovik DM, Daly MA, Potts JT, Neer RM (1984) Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone (1–34) administration in normal subjects. Clin Endocrinol (Oxf) 20: 369–375

    Article  CAS  Google Scholar 

  23. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372–374

    Article  CAS  PubMed  Google Scholar 

  24. Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL (1992) Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D and intestinal vitamin D receptor concentration in normal women. J Clin Endocrinol Metab 75:176–182

    CAS  PubMed  Google Scholar 

  25. Kinyamu H, Gallagher JC, DeLuca HF, Prahl J, Lanspa S, Knezetic J, Agarwal R (1995) Relationship between intestinal vitamin D receptor VDR genotypes, calcium absorption and serum 1,25(OH)2D in normal women. J Bone Miner Res 10(S1):162

    Google Scholar 

  26. Avioli LV, McDonald JE, Lee SW (1965) The influence of age on the intestinal absorption of 47Ca in women and its relation to 47Ca absorption in postmenopausal osteoporosis. J Clin Invest 44:1960–1967

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Nordin BE, Wilkinson R, Marshall DH, Gallager JC, Williams A, Peacock M (1976) Calcium absorption in the elderly. Calcif Tissue Res 21(suppl):442–451

    Article  PubMed  Google Scholar 

  28. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. Effect of age and dietary calcium. J Clin Invest 64: 729–736

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Heaney RP, Recker RR, Stegman MR, Moy AJ (1989) Calcium absorption in women: relationship to calcium intake, estrogen status and age. J Bone Miner Res 4:469–475

    Article  CAS  PubMed  Google Scholar 

  30. Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Riggs BL (1991) Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res 6:125–132

    Article  CAS  PubMed  Google Scholar 

  31. Ebeling PR, Yergey AL, Vieira NE, Burritt MF, O’Fallon WM, Kumar R, Riggs BL (1994) Influence of age on effects of endogenous 1,25-dihydroxyvitamin D on calcium absorption in normal women. Calcif Tissue Int 55(5):330–334

    Article  CAS  PubMed  Google Scholar 

  32. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Wilske J, Bengtsson BÅ (1995) Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure and vitamin D. Calcif Tissue Int 56:104–108

    Article  CAS  PubMed  Google Scholar 

  33. Ledger GA, Burritt MF, Kao PC, O’Fallon WM, Riggs BL, Khosla S (1995) Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short-term therapy with 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 79: 211–216

    Google Scholar 

  34. Åkesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gärdsell P, Obrant KJ (1995) Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women. J Bone Miner Res 10:1823–1829

    Article  PubMed  Google Scholar 

  35. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337–434

    Article  CAS  PubMed  Google Scholar 

  36. Stauffer M, Baylink D, Wergedal J, Rich C (1973) Decreased bone formation and mineralization, and enhanced resorption in calcium-deficient rats. Am J Physiol 225:269–276

    CAS  PubMed  Google Scholar 

  37. Scharla SH, Strong DD, Mohan S, Baylink DJ, Linkhart TA (1991) 1,25-dihydroxyvitamin D3 differentially regulates the production of IGF-I and IGFBP-4 in mouse osteoblasts. Endocrinology 129:3139–3146

    Article  CAS  PubMed  Google Scholar 

  38. Mohan S, Strong DD, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ (1992) Studies on the regulation of insulin-like growth factor binding protein (IGFBP)-3 and BP-4 production in human bone cells. Acta Endocrinol 127:555–564

    CAS  PubMed  Google Scholar 

  39. Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ (1992) The 24/25-kDa serum insulin-like growth factor binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 74:24–27

    CAS  PubMed  Google Scholar 

  40. Howard GA, Turner RT, Sherrard DJ, Baylink DJ (1981) Human bone cells in culture metabolize 25(OH)D3 to 1,25-(OH)2D3. J Biol Chem 256:7738–7740

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Åkesson, K., Lau, K.H.W. & Baylink, D.J. Rationale for active vitamin D analog therapy in senile osteoporosis. Calcif Tissue Int 60, 100–105 (1997). https://doi.org/10.1007/s002239900195

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900195

Keywords

Navigation